Maximilian Hoffmann
Leipzig, SN 04103, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
PPARγ controls I3C-mediated anti-inflammatory effects through the NF-κB/IL-6 pathway on gut inflammation models.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 24, 2026
Radiation-induced morphea of the breast - characterization and treatment of fibroblast dysfunction with repurposed mesalazine.
Journal: Scientific reports
Published: May 21, 2024
Investigation of mesalazine as an antifibrotic drug following myocardial infarction in male mice.
Journal: Physiological reports
Published: June 23, 2023
Diminished PLK2 Induces Cardiac Fibrosis and Promotes Atrial Fibrillation.
Journal: Circulation research
Published: August 26, 2021
Systemic mesalazine treatment prevents spontaneous skin fibrosis in PLK2-deficient mice.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: June 15, 2021
Genetic Deletion of Polo-Like Kinase 2 Induces a Pro-Fibrotic Pulmonary Phenotype.
Journal: Cells
Published: January 23, 2021
Indol-3-Carbinol and Quercetin Ameliorate Chronic DSS-Induced Colitis in C57BL/6 Mice by AhR-Mediated Anti-Inflammatory Mechanisms.
Journal: International journal of environmental research and public health
Published: December 31, 2020
Repurposing mesalazine against cardiac fibrosis in vitro.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: September 18, 2020
Disease Development Is Accompanied by Changes in Bacterial Protein Abundance and Functions in a Refined Model of Dextran Sulfate Sodium (DSS)-Induced Colitis.
Journal: Journal of proteome research
Published: February 16, 2019
A refined and translationally relevant model of chronic DSS colitis in BALB/c mice.
Journal: Laboratory animals
Published: December 02, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026